IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 194 filers reported holding IVERIC BIO INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,573,288 | +11.7% | 217,928 | -30.9% | 0.05% | -7.7% |
| Q1 2023 | $7,675,336 | -10.0% | 315,468 | -20.8% | 0.05% | -26.8% |
| Q4 2022 | $8,528,802 | +27.5% | 398,356 | +6.9% | 0.07% | 0.0% |
| Q3 2022 | $6,687,000 | +98.3% | 372,762 | +6.3% | 0.07% | +129.0% |
| Q2 2022 | $3,373,000 | -38.6% | 350,616 | +7.4% | 0.03% | -6.1% |
| Q1 2022 | $5,492,000 | -9.1% | 326,314 | -9.7% | 0.03% | +3.1% |
| Q4 2021 | $6,043,000 | +117.7% | 361,429 | +111.5% | 0.03% | +68.4% |
| Q3 2021 | $2,776,000 | +361.1% | 170,914 | +79.2% | 0.02% | +375.0% |
| Q2 2021 | $602,000 | -38.2% | 95,371 | -39.5% | 0.00% | -42.9% |
| Q1 2021 | $974,000 | +368.3% | 157,667 | +424.0% | 0.01% | +250.0% |
| Q4 2020 | $208,000 | – | 30,089 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 2,914,250 | $28,035,000 | 11.91% |
| Ally Bridge Group (NY) LLC | 650,000 | $6,253,000 | 5.70% |
| Vivo Capital, LLC | 5,238,634 | $50,396,000 | 5.06% |
| COMMODORE CAPITAL LP | 2,409,961 | $23,184,000 | 4.90% |
| Finepoint Capital LP | 987,600 | $9,501,000 | 3.28% |
| ACUTA CAPITAL PARTNERS, LLC | 563,607 | $5,422,000 | 3.02% |
| Deep Track Capital, LP | 4,500,000 | $43,290,000 | 2.85% |
| Yiheng Capital Management, L.P. | 5,058,585 | $48,664,000 | 2.78% |
| Samsara BioCapital, LLC | 1,010,051 | $9,717,000 | 2.59% |
| Ghost Tree Capital, LLC | 500,000 | $4,810,000 | 2.50% |